tykhr
sign in
free sign up
Maze Therapeutics, Inc. Common Stock
Biotechnology
Healthcare
MAZE
43.85 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
23.38
52 week high
24.88
high
25.17
52 week low
0.00
low
23.34
growth
91.38 %
previous Close
23.67
P/E ratio
market cap
525 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
-33.68 M
-2.72 %
eps
0.00 %
-2.59 %
eps surprise
0.00 %
net profit margin
-3367900000.00 %
0.00 %
operating incoming
-36.47 M
-3.03 %
net change in cash
-29.83 M
-130.58 %
cash on hand
265 M
-10.13 %
cost of revenue
649 K
0.00 %
top